Treatment Implications for Men When Switching From Male to Female Bone Mineral Density Reference Data: The Manitoba Bone Density Program

被引:2
作者
Leslie, William D. [1 ]
Majumdar, Sumit R. [2 ]
机构
[1] Univ Manitoba, Dept Med, Winnipeg, MB R2H 2A6, Canada
[2] Univ Alberta, Dept Med, Edmonton, AB, Canada
关键词
Absolute risk; dual-energy x-ray absorptiometry; FRAX; men; osteoporosis; FRACTURE RISK; CLINICAL-PRACTICE; HIP FRACTURE; OSTEOPOROTIC FRACTURES; WOMEN; DENSITOMETRY; THRESHOLDS; PREDICTION; VALIDATION; GUIDELINES;
D O I
10.1016/j.jocd.2013.07.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since 2001, the International Society for Clinical Densitometry Official Position has been to use a young female normative database in women and a young male normative in men for T-scores. Several prospective studies have shown that men and women with identical hip bone mineral density (BMD) have the same fracture rates, and so there has been reconsideration of whether female reference. data should be adopted for men. We studied 4691 men age 50 yr and older with baseline dual-energy X-ray absorptiometry assessments to explore how a change in BMD reference data from male to female would affect the number of men meeting National Osteoporosis Foundation (NOF) intervention criteria. We found that use of male vs female BMD reference data for T-score calculation did affect individual eligibility criteria for treatment under the NOF guidelines, but that overall differences in treatment rates were small when eligibility for treatment considered any of the NOF intervention criteria. Specifically, the majority of men who no longer qualified for treatment based upon T-scores calculated from female as opposed to male reference data would still qualify for treatment based upon other NOF intervention criteria. In addition, men only eligible for treatment under NOF criteria when using male reference data were at low fracture risk. We conclude that choice of male or female reference data for T-score calculation in men has little effect on overall treatment eligibility rates under NOF guidelines.
引用
收藏
页码:537 / 542
页数:6
相关论文
共 30 条
[1]  
[Anonymous], 2013, CLIN GUID PREV TREAT
[2]  
Binkley Neil C, 2002, J Clin Densitom, V5 Suppl, pS19, DOI 10.1385/JCD:5:3S:S19
[3]   Low bone mineral density and fracture burden in postmenopausal women [J].
Cranney, Ann ;
Jamal, Sophie A. ;
Tsang, James F. ;
Josse, Robert G. ;
Leslie, William D. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 177 (06) :575-580
[4]   The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008 [J].
Dawson-Hughes, B. ;
Looker, A. C. ;
Tosteson, A. N. A. ;
Johansson, H. ;
Kanis, J. A. ;
Melton, L. J., III .
OSTEOPOROSIS INTERNATIONAL, 2012, 23 (03) :811-820
[5]   Osteoporosis in men and women: A story about bone mineral density thresholds and hip fracture risk [J].
De Laet, CEDH ;
Van der Klift, M ;
Hofman, A ;
Pols, HAP .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (12) :2231-2236
[6]   Osteoporosis in men [J].
Ebeling, Peter R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14) :1474-1482
[7]   Updated fracture incidence rates for the US version of FRAXA® [J].
Ettinger, B. ;
Black, D. M. ;
Dawson-Hughes, B. ;
Pressman, A. R. ;
Melton, L. J., III .
OSTEOPOROSIS INTERNATIONAL, 2010, 21 (01) :25-33
[8]   Fracture prediction and calibration of a Canadian FRAXA® tool: a population-based report from CaMos [J].
Fraser, L-A. ;
Langsetmo, L. ;
Berger, C. ;
Ioannidis, G. ;
Goltzman, D. ;
Adachi, J. D. ;
Papaioannou, A. ;
Josse, R. ;
Kovacs, C. S. ;
Olszynski, W. P. ;
Towheed, T. ;
Hanley, D. A. ;
Kaiser, S. M. ;
Prior, J. ;
Jamal, S. ;
Kreiger, N. ;
Brown, J. P. ;
Johansson, H. ;
Oden, A. ;
McCloskey, E. ;
Kanis, J. A. ;
Leslie, W. D. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) :829-837
[9]   The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women [J].
Kanis, J. A. ;
Oden, A. ;
Johnell, O. ;
Johansson, H. ;
De Laet, C. ;
Brown, J. ;
Burckhardt, P. ;
Cooper, C. ;
Christiansen, C. ;
Cummings, S. ;
Eisman, J. A. ;
Fujiwara, S. ;
Glueer, C. ;
Goltzman, D. ;
Hans, D. ;
Krieg, M.-A. ;
La Croix, A. ;
McCloskey, E. ;
Mellstrom, D. ;
Melton, L. J., III ;
Pols, H. ;
Reeve, J. ;
Sanders, K. ;
Schott, A.-M. ;
Silman, A. ;
Torgerson, D. ;
van Staa, T. ;
Watts, N. B. ;
Yoshimura, N. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (08) :1033-1046
[10]   Towards a diagnostic and therapeutic consensus in male osteoporosis [J].
Kanis, J. A. ;
Bianchi, G. ;
Bilezikian, J. P. ;
Kaufman, J. -M. ;
Khosla, S. ;
Orwoll, E. ;
Seeman, E. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (11) :2789-2798